Pharmaceutical salts of reboxetine

Details for Australian Patent Application No. 2003227755 (hide)

Owner Pfizer Italia S.r.l.

Inventors Martini, Alessandro; Airoldi, Annalisa; Zampieri, Massimo

Agent Spruson & Ferguson

Pub. Number AU-B-2003227755

PCT Number PCT/EP03/05261

PCT Pub. Number WO2003/106441

Priority 02077366.9 17.06.02 EP

Filing date 4 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 15 January 2009

International Classifications

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/02 (2006.01) Drugs for disorders of the metabolism

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/06 (2006.01) Drugs for disorders of the endocrine system

A61P 5/24 (2006.01) Drugs for disorders of the endocrine system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

A61P 25/36 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 02077366.9 17.06.02 EP

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003227755

22 May 2008 Assignment before Grant

  Pharmacia Italia S.p.A. The application has been assigned to Pfizer Italia S.r.l.

15 January 2009 Application Accepted

  Published as AU-B-2003227755

14 May 2009 Standard Patent Sealed

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003227756-SELF-CLEANING SYNTHETIC BODY AND METHOD FOR PRODUCING THE SAME

2003227754-POWER AMPLIFIERS